NCT01371812View on ClinicalTrials.gov

GSK2239633 FTIH Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 29, 2011

Primary Completion Date

July 1, 2011

Study Completion Date

July 1, 2011

Conditions
Asthma
Interventions
DRUG

GSK2239633

Drug will be orally administered at the doses and time points detailed in the 'arms' section.

DRUG

Placebo

Placebo will be orally administered to 4 subjects in each treatment period of each cohort.

Trial Locations (1)

9471 GP

GSK Investigational Site, Zuidlaren

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY